FluMist & Acambis pass advisory committee
Executive Summary
Both MedImmune's influenza virus vaccine FluMist and Acambis' live vaccinia virus smallpox vaccine ACAM2000 received positive recommendations from FDA's Vaccines and Related Biological Products Advisory Committee on May 16-17. The committee voted 9-6 that benefits of FluMist exceed risk in MedImmune's proposed population of children aged 12-59 months without a history of wheeze. ACAM2000 received unanimous approval for both safety and efficacy from the committee...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.